NCT03561805View on ClinicalTrials.gov

Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation

NAActive, not recruitingINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

June 1, 2026

Conditions
Aortic Valve StenosisArrythmia
Interventions
DEVICE

ECG monitoring

Prolonged continuous ECG monitoring using the CardioSTAT® device within the 3 months prior to the TAVI procedure

Trial Locations (1)

G1V 4G5

IUCPQ, Québec

All Listed Sponsors
lead

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

OTHER

NCT03561805 - Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation | Biotech Hunter | Biotech Hunter